Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assure the inheritance of information, which are essential for the proper expression of key regulatory genes in healthy cells, tissues and organs. In the medical field, an increasing body of evidence indicates that altered gene expression or de-regulated gene function lead to disease. Cancer cells also suffer a profound change in the genomic methylation patterns and chromatin status. Aberrant DNA methylation patterns, changes in chromatin structure and in gene expression are common in all kind of tumor types. However, studies on leukemias have provided paradigmatic examples for the functional implications of the epigenetic alterations in cancer development and progression as well as their relevance for therapeutical targeting.

Leone, G., D'Alò, F., Zardo, G., Voso, M.t., Nervi, C. (2008). Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias. CURRENT MEDICINAL CHEMISTRY, 15(13), 1274-1287.

Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias

VOSO, MARIA TERESA;
2008-01-01

Abstract

Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assure the inheritance of information, which are essential for the proper expression of key regulatory genes in healthy cells, tissues and organs. In the medical field, an increasing body of evidence indicates that altered gene expression or de-regulated gene function lead to disease. Cancer cells also suffer a profound change in the genomic methylation patterns and chromatin status. Aberrant DNA methylation patterns, changes in chromatin structure and in gene expression are common in all kind of tumor types. However, studies on leukemias have provided paradigmatic examples for the functional implications of the epigenetic alterations in cancer development and progression as well as their relevance for therapeutical targeting.
2008
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/15 - MALATTIE DEL SANGUE
English
DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Leone, G., D'Alò, F., Zardo, G., Voso, M.t., Nervi, C. (2008). Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias. CURRENT MEDICINAL CHEMISTRY, 15(13), 1274-1287.
Leone, G; D'Alò, F; Zardo, G; Voso, Mt; Nervi, C
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/118228
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 37
social impact